Marcella Trombetta

Marcella Trombetta

Auto-generated profile, based on publicly available information

Marcella Trombetta

Department of “Science and Technology for Sustainable Development and One Health”, Università Campus Bio-Medico di Roma (UCBM), 00128 Rome, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Acta Biomaterialia
Verified
Journal Article
Closed access
SGS.M. Giannitelli
S.M. Giannitelli
Dino AccotoDino Accoto
Dino Accoto
MTM. Trombetta
M. Trombetta
Alberto RainerAlberto Rainer
Alberto Rainer

21 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FBFrancesca R. Bertani
Francesca R. Bertani
PMPamela Mozetic
Pamela Mozetic
MFMarco Fioramonti
Marco Fioramonti
MIMichele Iuliani
Michele Iuliani
GRGiulia Ribelli
Giulia Ribelli
Alberto RainerAlberto Rainer
Alberto Rainer
The possibility of detecting and classifying living cells in a label-free and non-invasive manner holds significant theranostic potential. In this work, Hyperspectral Imaging (HSI) has been successfully applied to the analysis of macrophagic polarization, given its central role in several pathological settings, including the regulation of tumour microenvironment. Human monocyte derived macrophages have been investigated using hyperspectral reflectance confocal microscopy, and hyperspectral datasets have been analysed in terms of M1 vs. M2 polarization by Principal Components Analysis (PCA). Following PCA, Linear Discriminant Analysis has been implemented for semi-automatic classification of macrophagic polarization from HSI data. Our results confirm the possibility to perform single-cell-level in vitro classification of M1 vs. M2 macrophages in a non-invasive and label-free manner with a high accuracy (above 98% for cells deriving from the same donor), supporting the idea of applying the technique to the study of complex interacting cellular systems, such in the case of tumour-immunity in vitro models.

1 October 1998 in Journal of Catalysis
Verified
Journal Article
Closed access
MTMarcella Trombetta
Marcella Trombetta
Guido BuscaGuido Busca
Guido Busca
SRStefano Rossini
Stefano Rossini
VPValerio Piccoli
Valerio Piccoli
UCUgo Cornaro
Ugo Cornaro
RWRonald J. Willey
Ronald J. Willey

29 March 2021 in Gels
Verified
Journal Article
Open access
PDF file
Emanuele MauriEmanuele Mauri
Emanuele Mauri
Sara Maria GiannitelliSara Maria Giannitelli
Sara Maria Giannitelli
MTMarcella Trombetta
Marcella Trombetta
Alberto RainerAlberto Rainer
Alberto Rainer
Nanogels represent an innovative platform for tunable drug release and targeted therapy in several biomedical applications, ranging from cancer to neurological disorders. The design of these nanocarriers is a pivotal topic investigated by the researchers over the years, with the aim to optimize the procedures and provide advanced nanomaterials. Chemical reactions, physical interactions and the developments of engineered devices are the three main areas explored to overcome the shortcomings of the traditional nanofabrication approaches. This review proposes a focus on the current techniques used in nanogel design, highlighting the upgrades in physico-chemical methodologies, microfluidics and 3D printing. Polymers and biomolecules can be combined to produce ad hoc nanonetworks according to the final curative aims, preserving the criteria of biocompatibility and biodegradability. Controlled polymerization, interfacial reactions, sol-gel transition, manipulation of the fluids at the nanoscale, lab-on-a-chip technology and 3D printing are the leading strategies to lean on in the next future and offer new solutions to the critical healthcare scenarios.

1 December 1996 in Applied Catalysis B: Environment and Energy
Verified
Journal Article
Closed access
Luis J. AlemanyLuis J. Alemany
Luis J. Alemany
FBFrancesco Berti
Francesco Berti
Guido BuscaGuido Busca
Guido Busca
Gianguido RamisGianguido Ramis
Gianguido Ramis
DRDavide Robba
Davide Robba
MTMarcella Trombetta
Marcella Trombetta

1 March 2010 in Biofabrication
Verified
Journal Article
Closed access
MCM Centola
M Centola
Alberto RainerAlberto Rainer
Alberto Rainer
CSC Spadaccio
C Spadaccio
SPS De Porcellinis
S De Porcellinis
JGJ A Genovese
J A Genovese
MTM Trombetta
M Trombetta
Tissue engineering of blood vessels is a promising strategy in regenerative medicine with a broad spectrum of potential applications. However, many hurdles for tissue-engineered vascular grafts, such as poor mechanical properties, thrombogenicity and cell over-growth inside the construct, need to be overcome prior to the clinical application. To surmount these shortcomings, we developed a poly-L-lactide (PLLA)/poly-epsilon-caprolactone (PCL) scaffold releasing heparin by a combination of electrospinning and fused deposition modeling technique. PLLA/heparin scaffolds were produced by electrospinning in tubular shape and then fused deposition modeling was used to armor the tube with a single coil of PCL on the outer layer to improve mechanical properties. Scaffolds were then seeded with human mesenchymal stem cells (hMSCs) and assayed in terms of morphology, mechanical tensile strength, cell viability and differentiation. This particular scaffold design allowed the generation of both a drug delivery system amenable to surmount thrombogenic issues and a microenvironment able to induce endothelial differentiation. At the same time, the PCL external coiling improved mechanical resistance of the microfibrous scaffold. By the combination of two notable techniques in biofabrication--electrospinning and FDM--and exploiting the biological effects of heparin, we developed an ad hoc differentiating device for hMSCs seeding, able to induce differentiation into vascular endothelium.